HIV-1 Gp120 Activates the STAT3/interleukin-6 Axis in Primary Human Monocyte-derived Dendritic Cells
Overview
Authors
Affiliations
Unlabelled: Dendritic cells (DCs) are fundamental for the initiation of immune responses and are important players in AIDS immunopathogenesis. The modulation of DC functional activities represents a strategic mechanism for HIV-1 to evade immune surveillance. Impairment of DC function may result from bystander effects of HIV-1 envelope proteins independently of direct HIV-1 infection. In this study, we report that exposure of immature monocyte-derived DCs (MDDCs) to HIV-1 R5 gp120 resulted in the CCR5-dependent production of interleukin-6 (IL-6) via mitogen-activated protein kinase (MAPK)/NF-κB pathways. IL-6 in turn activated STAT3 by an autocrine loop. Concomitantly, gp120 promoted an early activation of STAT3 that further contributed to IL-6 induction. This activation paralleled a concomitant upregulation of the STAT3 inhibitor PIAS3. Notably, STAT3/IL-6 pathway activation was not affected by the CCR5-specific ligand CCL4. These results identify STAT3 as a key signaling intermediate activated by gp120 in MDDCs and highlight the existence of a virus-induced dysregulation of the IL-6/STAT3 axis. HIV-1 gp120 signaling through STAT3 may provide an explanation for the impairment of DC function observed upon HIV exposure.
Importance: This study provides new evidence for the molecular mechanisms and signaling pathways triggered by HIV-1 gp120 in human DCs in the absence of productive infection, emphasizing a role of aberrant signaling in early virus-host interaction, contributing to viral pathogenesis. We identified STAT3 as a key component in the gp120-mediated signaling cascade involving MAPK and NF-κB components and ultimately leading to IL-6 secretion. STAT3 now is recognized as a key regulator of DC functions. Thus, the identification of this transcription factor as a signaling molecule mediating some of gp120's biological effects unveils a new mechanism by which HIV-1 may deregulate DC functions and contribute to AIDS pathogenesis.
Capriotti Z, Klase Z J Neurovirol. 2024; 30(5-6):451-476.
PMID: 39733092 PMC: 11846772. DOI: 10.1007/s13365-024-01239-2.
HIV-1 Structural Proteins or Cell-Signaling Factors? That Is the Question!.
Pellegrino M, Giordano F, De Amicis F, Marra M, Tucci P, Marsico S Curr Issues Mol Biol. 2024; 46(6):5100-5116.
PMID: 38920978 PMC: 11202448. DOI: 10.3390/cimb46060306.
JAK/STAT signaling pathway affects CCR5 expression in human CD4 T cells.
Wang L, Yukselten Y, Nuwagaba J, Sutton R Sci Adv. 2024; 10(12):eadl0368.
PMID: 38507500 PMC: 10954213. DOI: 10.1126/sciadv.adl0368.
Dynamic modulation of the non-canonical NF-κB signaling pathway for HIV shock and kill.
Chandrasekar A, Maynes M, Badley A Front Cell Infect Microbiol. 2024; 14:1354502.
PMID: 38505285 PMC: 10949532. DOI: 10.3389/fcimb.2024.1354502.
The chemokine receptor CCR5: multi-faceted hook for HIV-1.
Faivre N, Verollet C, Dumas F Retrovirology. 2024; 21(1):2.
PMID: 38263120 PMC: 10807162. DOI: 10.1186/s12977-024-00634-1.